LYEL
Lyell Immunopharma Inc
9.60$
-1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.2% | 68.0% | 55.6% | 69.5% | 74.0% | 77.3% | 76.7% | |
| 17.4% | 15.5% | 26.1% | 13.2% | 19.4% | 21.5% | 17.7% | |
| 78.5% | 67.4% | 54.5% | 68.3% | 72.8% | 75.5% | 72.7% | |
| 7.9% | 13.7% | 10.7% | 17.7% | – | – | – | |
| 26.6% | 20.9% | 17.5% | 11.1% | 12.7% | 22.0% | 27.0% | |
| 4.0% | 5.4% | 4.1% | 3.9% | 4.6% | 11.0% | 14.5% | |
| 0.1% | 0.4% | 0.1% | 0.5% | 0.8% | 1.6% | 2.7% | |
| 0.5% | 1.0% | 0.3% | 0.4% | 0.6% | 1.1% | 0.9% | |
| 73.4% | 79.1% | 82.5% | 88.9% | 87.3% | 78.0% | 73.0% | |
| -23.3% | -36.8% | -51.8% | -81.9% | -133.6% | -274.0% | -476.3% | |
| 2.2% | 1.4% | 1.1% | 1.3% | 1.7% | 2.7% | 5.0% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.